Dr. Patricia Robinson and John McIlwain discuss the important issue of Diversity in Clinical Trails with Dr. Eddilisa Martin, owner and founder of M&B Sciences. Diversity in Clinical trials is becoming a more and more important topic as we address the impact of Systemic Racism in our Healthcare System. If trials to identify biomarkers or test new drugs exclude lived experiences from major segments of the American population, we are never going to truly get to equitable healthcare in this country.